Hjem › Metaboliske lidelser › Indiana
Metaboliske lidelser kliniske forsøg i Indiana
5 studier for Metaboliske lidelser søger deltagere på steder i Indiana.
Officiel studietekst (engelsk)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- MediSphere Medical Research Center, LLC, Evansville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
- Indiana University School of Medicine University Hospital, Indianapolis
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT06525636A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 3. sep. 2026 · NCT06419374Rare and Atypical Diabetes Network
- Indiana University, Indianapolis
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 14. aug. 2025 · NCT05544266Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.